Turning Baby Teeth Into Cell Therapy
SHED cells show early promise as a potential regenerative therapy in cerebral palsy research
Clinical Scorecard: Turning Baby Teeth Into Cell Therapy
At a Glance
Category Detail
Condition Cerebral Palsy Key Mechanisms Neurotrophic and immunomodulatory properties of SHED cells may support neuronal repair and reduce inflammation. Target Population Children with cerebral palsy Care Setting Clinical investigation under controlled conditions
Key Highlights
SHED cells derived from exfoliated deciduous teeth show potential for treating cerebral palsy. The treatment was generally well tolerated with no serious adverse events reported. Some participants exhibited improvements in motor and functional assessments post-treatment. SHED cells can be collected noninvasively and expanded in laboratory culture. Further research is needed to confirm long-term safety and effectiveness. Guideline-Based Recommendations
Diagnosis
Assess cerebral palsy based on clinical evaluation and history of early brain injury. Management
Current treatment focuses on rehabilitation, physical therapy, and symptom management. Monitoring & Follow-up
Monitor patients for safety and functional outcomes following SHED cell administration. Risks
No serious adverse events linked to SHED administration reported; however, long-term risks remain unknown. Patient & Prescribing Data
Pediatric patients diagnosed with cerebral palsy.
SHED-based therapy shows promise but requires larger trials for validation.
Clinical Best Practices
Consider SHED cells as a noninvasive option for regenerative therapy in pediatric patients. Conduct larger controlled trials to evaluate treatment effectiveness and safety. Related Resources & Content
